These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. Sánchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Rodríguez Garay EA, Mottino AD. J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690 [Abstract] [Full Text] [Related]
3. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis. Lukivskaya O, Zavodnik L, Knas M, Buko V. Adv Med Sci; 2006 Jul; 51():54-9. PubMed ID: 17357278 [Abstract] [Full Text] [Related]
4. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats. Barone M, Maiorano E, Ladisa R, Pece A, Berloco P, Strazzabosco M, Caruso ML, Valentini AM, Ierardi E, Di Leo A, Francavilla A. Virchows Arch; 2004 Jun; 444(6):554-60. PubMed ID: 15071740 [Abstract] [Full Text] [Related]
5. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Barone M, Maiorano E, Ladisa R, Cuomo R, Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla A, Di Leo A, Ierardi E. Hepatology; 2003 Apr; 37(4):880-6. PubMed ID: 12668981 [Abstract] [Full Text] [Related]
6. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. Crocenzi FA, D'Andrea V, Catania VA, Luquita MG, Pellegrino JM, Ochoa JE, Mottino AD, Sánchez Pozzi EJ. Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489 [Abstract] [Full Text] [Related]
8. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. Macias RI, Serrano MA, Monte MJ, Jimenez S, Hernandez B, Marin JJ. J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192 [Abstract] [Full Text] [Related]
11. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis. Smith DJ, Gordon ER. J Lab Clin Med; 1988 Dec; 112(6):679-85. PubMed ID: 3193023 [Abstract] [Full Text] [Related]
12. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat. Accatino L, Pizarro M, Solís N, Koenig CS. Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105 [Abstract] [Full Text] [Related]
13. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Rost D, Herrmann T, Sauer P, Schmidts HL, Stieger B, Meier PJ, Stremmel W, Stiehl A. Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001 [Abstract] [Full Text] [Related]
15. Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity. Neubrand MW, Dominguez-Munoz JE, Reichel C, Kampmann S, Eschmann K, von Falkenhausen M, Bregulla M, Malfertheiner P, Sauerbruch T. Digestion; 2004 Jul; 69(3):149-57. PubMed ID: 15114045 [Abstract] [Full Text] [Related]
17. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects. Mazzella G, Cipolla A, Villanova N, Polimeni C, Sipahi A, Parini P, Fusaroli P, Festi D, Roda E. Ital J Gastroenterol; 1995 Jul; 27(8):441-5. PubMed ID: 8775472 [Abstract] [Full Text] [Related]